Blog Index
The journal that this archive was targeting has been deleted. Please update your configuration.
« Ultra-Lyte® shown to inactivate live human norovirus | Main | Clarentis Technologies' electrolytic cells do not contain any RoHS restricted substances »

CLARENTIS® Intellectual Property Update

May 24th, 2016

The United States Patent Office has issued US patent application13/092,653, Van Kalken/Waldner, “System and Method for preparation for antimicrobial solutions”, as US 9,347,140.

In addition, CLARENTIS has made a new patent application, “Van Kalken/Waldner, 15/162,076,  “Cell and System for the preparation of antimicrobial Solutions”, a divisional application of 14/694,334.

CLARENTIS has four patents issued in the United States that protect its proprietary ECA Technology and that allows the company to manufacture ECA equipment to generate stabile hypochlorous acid (HOCl) cleaning, sanitizing and disinfecting solutions, with an extraordinary good salt conversion.

A sample of applications for CLARENTIS ECA Technology that require a minimum use of salt:

Agriculture, Animal Husbandry, Beverage Industry, Borehole remediation, Dairy, Healthcare, Food Processing, Hospitality, Mold Remediation, Oil & Gas, Pharmaceutical Industry and Waste water treatment.